These findings highlight the potential of OGT-mediated HDAC1 O-GlcNAcylation as a facilitator of HCC development, suggesting that targeting this modification could be a viable strategy to inhibit HCC progression [53]. This evidence concerns the gene OGT and hepatocellular carcinoma.